Literature DB >> 16401167

Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder.

Chih-Chiang Chiu, Shih-Yi Huang, Chiao-Chicy Chen, Kuan-Pin Su.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16401167     DOI: 10.4088/jcp.v66n1219b

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  24 in total

1.  Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.

Authors:  Erika Fh Saunders; Aubrey Reider; Gagan Singh; Alan J Gelenberg; Stanley I Rapoport
Journal:  Bipolar Disord       Date:  2015-10-01       Impact factor: 6.744

Review 2.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

Review 3.  Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.

Authors:  Konstantinos N Fountoulakis; Siegfried Kasper; Ole Andreassen; Pierre Blier; Ahmed Okasha; Emanuel Severus; Marcio Versiani; Rajiv Tandon; Hans-Jürgen Möller; Eduard Vieta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06       Impact factor: 5.270

Review 4.  Immune-based strategies for mood disorders: facts and challenges.

Authors:  Gabriela D Colpo; Marion Leboyer; Robert Dantzer; Mahdukar H Trivedi; Antonio L Teixeira
Journal:  Expert Rev Neurother       Date:  2017-11-27       Impact factor: 4.618

Review 5.  Targeting the immune system in the treatment of bipolar disorder.

Authors:  Joshua D Rosenblat
Journal:  Psychopharmacology (Berl)       Date:  2019-02-13       Impact factor: 4.530

6.  Reconsidering Dietary Polyunsaturated Fatty Acids in Bipolar Disorder: A Translational Picture.

Authors:  Erika F H Saunders; Christopher E Ramsden; Mostafa S Sherazy; Alan J Gelenberg; John M Davis; Stanley I Rapoport
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

7.  Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania.

Authors:  M Elizabeth Sublette; Francesca Bosetti; James C DeMar; Kaizong Ma; Jane M Bell; Stephanie Fagin-Jones; Mark J Russ; Stanley I Rapoport
Journal:  Bipolar Disord       Date:  2007-11       Impact factor: 6.744

Review 8.  (N-3) Fatty acids: molecular role and clinical uses in psychiatric disorders.

Authors:  Pedro Luis Prior; José Carlos Fernandes Galduróz
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

9.  A Systematic Review of Nutraceuticals for the Treatment of Bipolar Disorder.

Authors:  Melanie M Ashton; Bianca E Kavanagh; Wolfgang Marx; Michael Berk; Jerome Sarris; Chee H Ng; Malcolm Hopwood; Lana J Williams; Olivia M Dean
Journal:  Can J Psychiatry       Date:  2020-09-23       Impact factor: 4.356

Review 10.  Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature.

Authors:  Hans O Kalkman; Martin Hersberger; Suzanne Walitza; Gregor E Berger
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.